The best Side of nvesatim.info
Nije utvrđena bezbednost i efikasnost primene filgrastima kod pacijenata sa mijelodisplastičnim sindromom ili hroničnom mijeloidnom leukemijom.The advisable starting dosage of NIVESTYM is 5 mcg/kg/working dayâ???administered as a single day by day injection by subcutaneous injectionâ???by limited intravenous infusion (15 to thirty minutes)â??